Search tips
Search criteria 


Logo of jcinvestThe Journal of Clinical Investigation
J Clin Invest. 1987 September; 80(3): 691–697.
PMCID: PMC442292

Stochastic control of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice.


MRL/Mp-lpr/lpr autoimmune mice consistently show an approximately 25% incidence of the systemic lupus erythematosus marker autoantibody anti-Sm. In the present report, we show that the failure to find anti-Sm antibodies in three-quarters of 5-mo-old MRL/lpr mice was not an artifact of an insensitive assay, but rather that the mice fell into two populations as regards their anti-Sm positivity. Based on an extensive analysis of the incidence of anti-Sm positivity in 5-mo-old mice according to their cage of residence, we found no evidence for genetic, environmental, or parental influences on the propensity of an individual animal to become anti-Sm positive. Also, the gender of the mouse, its Sm antigen level, or its length of survival were not related to anti-Sm antibody, nor was the anti-Sm antibody status of either parent. Some animals became anti-Sm positive after 5 mo of age, but this was less likely than becoming positive before 5 mo of age. Finally, a survey of 205 autoimmune C57BL/6-lpr/lpr mice confirmed the uniqueness of the MRL background for this autoantibody response. These results together indicate that the possibility of making anti-Sm antibodies is under genetic control, but that the expression of this capability in an individual animal is governed by stochastic events. We hypothesize further that such random processes may involve the expression of particular immunoglobulin variable-region genes combined with mechanisms of extensive somatic mutation or positive feedback amplification, which would transmute an initial monoclonal response into an eventual polyclonal one.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Andrews BS, Eisenberg RA, Theofilopoulos AN, Izui S, Wilson CB, McConahey PJ, Murphy ED, Roths JB, Dixon FJ. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med. 1978 Nov 1;148(5):1198–1215. [PMC free article] [PubMed]
  • Pettersson I, Hinterberger M, Mimori T, Gottlieb E, Steitz JA. The structure of mammalian small nuclear ribonucleoproteins. Identification of multiple protein components reactive with anti-(U1)ribonucleoprotein and anti-Sm autoantibodies. J Biol Chem. 1984 May 10;259(9):5907–5914. [PubMed]
  • Eisenberg RA, Tan EM, Dixon FJ. Presence of anti-Sm reactivity in autoimmune mouse strains. J Exp Med. 1978 Feb 1;147(2):582–587. [PMC free article] [PubMed]
  • Notman DD, Kurata N, Tan EM. Profiles of antinuclear antibodies in systemic rheumatic diseases. Ann Intern Med. 1975 Oct;83(4):464–469. [PubMed]
  • Costa O, Fournel C, Lotchouang E, Monier JC, Fontaine M. Specificities of antinuclear antibodies detected in dogs with systemic lupus erythematosus. Vet Immunol Immunopathol. 1984 Oct;7(3-4):369–382. [PubMed]
  • Hochberg MC, Boyd RE, Ahearn JM, Arnett FC, Bias WB, Provost TT, Stevens MB. Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine (Baltimore) 1985 Sep;64(5):285–295. [PubMed]
  • Tan EM, Kunkel HG. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol. 1966 Mar;96(3):464–471. [PubMed]
  • Eisenberg RA, Klapper DG, Cohen PL. The polypeptide structure of the Sm and RNP nuclear antigens. Mol Immunol. 1983 Feb;20(2):187–195. [PubMed]
  • Eisenberg RA, Winfield JB, Cohen PL. Subclass restriction of anti-Sm antibodies in MRL mice. J Immunol. 1982 Nov;129(5):2146–2149. [PubMed]
  • Boyer CM, Eisenberg RA, Cohen PL. Quantitation of the Sm nuclear antigen in tissues and activated lymphocytes. Arthritis Rheum. 1985 Mar;28(3):294–299. [PubMed]
  • Winn DM, Wolfe JF, Lindberg DA, Fristoe FH, Kingsland L, Sharp GC. Identification of a clinical subset of systemic lupus erythematosus by antibodies to the SM antigen. Arthritis Rheum. 1979 Dec;22(12):1334–1337. [PubMed]
  • Winfield JB, Brunner CM, Koffler D. Serologic studies in patients with systemic lupus erythematosus and central nervous system dysfunction. Arthritis Rheum. 1978 Apr;21(3):289–294. [PubMed]
  • Munves EF, Schur PH. Antibodies to Sm and RNP. Prognosticators of disease involvement. Arthritis Rheum. 1983 Jul;26(7):848–853. [PubMed]
  • Portnoï D, Freitas A, Holmberg D, Bandeira A, Coutinho A. Immunocompetent autoreactive B lymphocytes are activated cycling cells in normal mice. J Exp Med. 1986 Jul 1;164(1):25–35. [PMC free article] [PubMed]
  • Cohen PL, Shores EW, Rapoport R, Caster S, Eisenberg RA, Pisetsky DS. Anti-Sm autoantibodies in MRL mice: analysis of precursor frequency. Cell Immunol. 1985 Dec;96(2):448–454. [PubMed]
  • Shores EW, Eisenberg RA, Cohen PL. Role of the Sm antigen in the generation of anti-Sm autoantibodies in the SLE-prone MRL mouse. J Immunol. 1986 May 15;136(10):3662–3667. [PubMed]
  • Eisenberg RA, Dyer K, Craven SY, Fuller CR, Yount WJ. Subclass restriction and polyclonality of the systemic lupus erythematosus marker antibody anti-Sm. J Clin Invest. 1985 Apr;75(4):1270–1277. [PMC free article] [PubMed]
  • Bernard NF, Eisenberg RA, Cohen PL. H-2-linked Ir gene control of T cell recognition of the Sm nuclear autoantigen and the aberrant response of autoimmune MRL/Mp-+/+ mice. J Immunol. 1985 Jun;134(6):3812–3818. [PubMed]
  • Cohen PL, Eisenberg RA. T cell recognition of the Sm nuclear antigen: induction of T cell proliferative responses in MRL/Mp- +/+ mice. J Immunol. 1982 Nov;129(5):2142–2145. [PubMed]
  • Perlmutter RM, Crews ST, Douglas R, Sorensen G, Johnson N, Nivera N, Gearhart PJ, Hood L. The generation of diversity in phosphorylcholine-binding antibodies. Adv Immunol. 1984;35:1–37. [PubMed]
  • Clarke SH, Huppi K, Ruezinsky D, Staudt L, Gerhard W, Weigert M. Inter- and intraclonal diversity in the antibody response to influenza hemagglutinin. J Exp Med. 1985 Apr 1;161(4):687–704. [PMC free article] [PubMed]
  • Brennan FM, Williams DG, Bovill D, Stocks MR, Maini RN. Administration of monoclonal anti-Sm antibody prolongs the survival and renal function of MRL-lpr/lpr mice. Clin Exp Immunol. 1986 Jul;65(1):42–50. [PubMed]
  • Block SR, Lockshin MD, Winfield JB, Weksler ME, Imamura M, Winchester RJ, Mellors RC, Christian CL. Immunologic observations on 9 sets of twins either concordant or discordant for SLE. Arthritis Rheum. 1976 May-Jun;19(3):545–554. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation